Amarin Corp Plc - Company Profile

Powered by

All the sales intelligence you need on Amarin Corp Plc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Amarin Corp Plc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Amarin Corp Plc.

Back to companies

Amarin Corp Plc: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Amarin Corp Plc Catalyst Calendar

Proactively evaluate Amarin Corp Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Amarin Corp Plc Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 16+ results.
01 Dec 2020 GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Lorem
01 Jun 2020 Phase II Trial Initiation Amarin Corp Plc; Canadian Medical and Surgical Knowledge Translation Research Group; HLS Therapeutics Inc AMRN; HLS icosapent ethyl Infectious Disease Coronavirus Disease 2019 (COVID-19) Clinical Trial Registry
31 Dec 2019 MAA Filing (EU) Amarin Corp Plc AMRN icosapent ethyl Cardiovascular Cardiovascular Risk Factors Company Press Release
28 Dec 2019 PDUFA Amarin Pharma Inc - icosapent ethyl Cardiovascular Cardiovascular Risk Factors Company Press Release
Catalyst Calendar

Feature

Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.

Benefit

Access:

  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)

Value

Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Gain a 360-degree view of Amarin Corp Plc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer